2024 Fall Senior Executive Conference


Sunday, September 29 (4pm) - Tuesday, October 1, 2024 (9:30am US/Pacific)
The Ritz-Carlton Half Moon Bay
One Miramontes Point Road [map]
Half Moon Bay, CA 94019

"2024_Fall_Senior_Exec_Conference"


For more information and FAQs, please check out our webpage at http://www.thealda.org/halfmoonbay2024!

The Fall Senior Executives Conference is one of our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams. Each meeting focuses on emerging trends and business strategies and offers great insights and advice, along with many opportunities for dialogue with other senior executive attendees.

Past meetings have focused on proteomics, artificial intelligence, immunology, the transformation of healthcare and trends in pharma. We include a global economic and financial outlook to complement each topical program.

This year's conference will focus on “Innovations in Multi-omics”, exploring the integration of diverse biological data sets such as genomics, proteomics, metabolomics, and more. This interdisciplinary approach offers invaluable insights into complex biological systems, revolutionizing personalized medicine, drug discovery, and diagnostics.

Monday, September 30
“Multi-omics” programming. More speakers will be announced soon.

From Data to Discovery: Harnessing the Power of Multi-omics
Presented by:
Michael Snyder, Ph.D.
Chair, Dept. of Genetics, Director, Center for Genomics and Personalized Medicine
Stanford Medicine

Dr. Mike Snyder--a leading expert in the field of genomics and personalized medicine-- will present a comprehensive overview of the multi-omics landscape. This session will explore the relevance of multi-omics to enhancing our understanding of complex biological systems and diseases, offering insights into how this integrative approach can lead to more precise and predictive healthcare solutions. Dr. Snyder will also discuss the impact of multi-omics on drug development, disease diagnosis, and personalized treatment plans, highlighting practical applications that could benefit executive members and their companies.

Applications of AI in Multi-omics Analysis
Presented by:
Dr. Russ Altman, PhD
Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science, and (by courtesy) Computer Science
Past chairman of the Bioengineering Department
Stanford University

Dr. Russ Altman, a distinguished professor at Stanford University and a pioneer in the field of bioinformatics, will delve into the intersection of artificial intelligence and multi-omics during his session. Drawing from his wide-ranging expertise, attendees can anticipate gaining invaluable insights into the transformative potential of AI-driven approaches in deciphering complex biological data. Don’t miss this opportunity to explore the cutting-edge applications of AI in multi-omics analysis with one of the foremost experts in the field.

Tuesday, October 1
Keynote session

Dr. Jennifer Doudna

We’re honored to welcome Dr. Jennifer Doudna, PhD, as our esteemed keynote speaker. Dr. Doudna, a Nobel laureate honored in 2020 for her pioneering work in CRISPR technology, stands as a beacon of innovation in the field of genomics and molecular biology. As the co-inventor of CRISPR-Cas9 gene editing, her research has revolutionized our understanding of genetic engineering and its applications in medicine, agriculture, and beyond.

During her keynote session, Dr. Doudna will share invaluable insights from her experiences at the forefront of genomic innovation. From navigating ethical considerations in gene editing to harnessing CRISPR’s potential for transformative therapies, attendees can expect a thought-provoking discussion that delves into both the promise and the challenges of genomic advancements. With her engaging and approachable style, Dr. Doudna will inspire attendees to embrace innovation responsibly while charting the course for the future in our industry. This will be a truly enlightening session!


Related Web Pages and Sites:
More details and Conference FAQs!

Who Should Attend:

Our semi-annual meetings designed for member company C-suite executives, presidents and their senior executive teams.

Registration Fees:

These fees are available through 09/27/2024
Name Price Available To
First Registrant $2,795.00   Member
Additional Registrants $2,295.00   Member


Cancellation and Other Policies:

**No refunds of Conference registration fees will be made for registration cancellations after Friday, September 20, however, if you must cancel, please remember that you are also responsible for canceling your hotel reservations.

For more information please contact:

Carol Starke
Manager, Meetings & Administration
Analytical, Life Science & Diagnostics Association (ALDA)
Phone: (703) 647-6361
Email: CStarke@thealda.org